Humanigen Inc (HGENQ)

[cowtown jay]

You vacillated, but you ultimately bit the bullet and you have a guaranteed payout of just under $200K. So I hope your exit strategy may not necessarily be binary, and that you don't "go home broke."

Your acquisition certainly sent a signal to the shorts that the bankruptcy has not deterred retail interest in this stock.

But I think the Q suffix was timed to coincide with management's conclusion of the accumulation of shares in preparation for the recall of the company's loaned shares. Note the share volume in the two days preceding the Q designation on the 5th.

https://ih.advfn.com/stock-market/USOTC/humanigen-ce-HGEN/historical/more-historical-data

My guess is that management provided those shares for you, and that's why I think our ownership of the company may have been reduced from 92% to 89%. I think it was a very generous and gracious display of management's consideration of a shareholder. I think they provided just enough shares to keep you from filing Beneficial Ownership documentation.

I mentioned the 89-92% control in a separate post. "I've been wondering if Dale's Appeal hearing might force disclosure regarding the amount of Humanigen stock controlled by the company, which I think could range from 89-92%, which would cause one heck of a short squeeze, if the company recalled their loaned shares, and would mean that the bankruptcy petition could be withdrawn."

The company may not want to withdraw the bankruptcy petition. But I mention it because I doubt that the objections being filed are considering this possibility.

However, I think that our partners are likely aware of the company's strategy. After all, they are incurring most of the trial costs for CAR-T, CMML, and AGvHD.

Of particular note is the lack of recognizing the covid opportunity. Management has not chosen to recognize a partnership for this indication, which I think will result in more revenue, and save more lives, than all of the other indications combined. I've made clear my own opinion that Novavax may prove to be a partner for us by using the lenz vaccine cocktail, and expanding our market upstream of hospitalized covid patients, to include the prophylaxis use of lenz.

Shareholders are on the threshold of life-changing reward, and the whole world is on the threshold of having a life-saving covid vaccine and therapeutic.